1-3 of 3
Jostein Gleditsch
Close
Sort by
Journal Articles

Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis

Clinical Trials & Observations
Lisette F. van Dam, Wilbert B. van den Hout, Gargi Gautam, Charlotte E. A. Dronkers, Waleed Ghanima, Jostein Gleditsch, Anders von Heijne, Herman M. A. Hofstee, Marcel M. C. Hovens, Menno V. Huisman, Stan Kolman, Albert T. A. Mairuhu, Mathilde Nijkeuter, Marcel A. van de Ree, Cornelis J. van Rooden, Robin E. Westerbeek, Jan Westerink, Eli Westerlund, Lucia J. M. Kroft, Frederikus A. Klok
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1369–1378.
https://doi.org/10.1182/bloodadvances.2020003849
Published: 2021
Includes: Supplemental data
Journal Articles

Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis

Clinical Trials & Observations
Synne G. Fronas, Camilla T. Jørgensen, Anders E. A. Dahm, Hilde S. Wik, Jostein Gleditsch, Nezar Raouf, René Holst, F. A. Klok, Waleed Ghanima
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5002–5010.
https://doi.org/10.1182/bloodadvances.2020002173
Published: 2020
Journal Articles

Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis

Clinical Trials & Observations
Synne G. Fronas, Anders E. A. Dahm, Hilde S. Wik, Camilla T. Jørgensen, Jostein Gleditsch, Nezar Raouf, René Holst, Frederikus A. Klok, Waleed Ghanima
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2468–2476.
https://doi.org/10.1182/bloodadvances.2020001556
Published: 2020